[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Lipid-lowering Agent Market Report 2017

August 2017 | 112 pages | ID: UBAD7E64C19EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Lipid-lowering Agent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Lipid-lowering Agent in these regions, from 2012 to 2022 (forecast).
United States Lipid-lowering Agent market competition by top manufacturers/players, with Lipid-lowering Agent sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Merck
  • Teva
  • Amgen
  • Abbott
  • AstraZeneca
  • Novartis
  • SUN Pharma
  • Torrent Pharmaceuticals
  • GlaxoSmithKline
  • HanAll BioPharma
  • JX Pharmaceuticals
  • Aurobindo Pharma
  • Abbvie
  • Cerenis Therapeutics
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Niaci
  • Acipimox
  • Fibrates
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Lipid-lowering Agent for each application, including
  • Hospitals
  • Clinics
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Lipid-lowering Agent Market Report 2017

1 LIPID-LOWERING AGENT OVERVIEW

1.1 Product Overview and Scope of Lipid-lowering Agent
1.2 Classification of Lipid-lowering Agent by Product Category
  1.2.1 United States Lipid-lowering Agent Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lipid-lowering Agent Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Niaci
  1.2.4 Acipimox
  1.2.5 Fibrates
  1.2.6 Others
1.3 United States Lipid-lowering Agent Market by Application/End Users
  1.3.1 United States Lipid-lowering Agent Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Others
1.4 United States Lipid-lowering Agent Market by Region
  1.4.1 United States Lipid-lowering Agent Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lipid-lowering Agent Status and Prospect (2012-2022)
  1.4.3 Southwest Lipid-lowering Agent Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lipid-lowering Agent Status and Prospect (2012-2022)
  1.4.5 New England Lipid-lowering Agent Status and Prospect (2012-2022)
  1.4.6 The South Lipid-lowering Agent Status and Prospect (2012-2022)
  1.4.7 The Midwest Lipid-lowering Agent Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lipid-lowering Agent (2012-2022)
  1.5.1 United States Lipid-lowering Agent Sales and Growth Rate (2012-2022)
  1.5.2 United States Lipid-lowering Agent Revenue and Growth Rate (2012-2022)

2 UNITED STATES LIPID-LOWERING AGENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lipid-lowering Agent Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lipid-lowering Agent Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lipid-lowering Agent Average Price by Players/Suppliers (2012-2017)
2.4 United States Lipid-lowering Agent Market Competitive Situation and Trends
  2.4.1 United States Lipid-lowering Agent Market Concentration Rate
  2.4.2 United States Lipid-lowering Agent Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lipid-lowering Agent Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIPID-LOWERING AGENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lipid-lowering Agent Sales and Market Share by Region (2012-2017)
3.2 United States Lipid-lowering Agent Revenue and Market Share by Region (2012-2017)
3.3 United States Lipid-lowering Agent Price by Region (2012-2017)

4 UNITED STATES LIPID-LOWERING AGENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lipid-lowering Agent Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lipid-lowering Agent Revenue and Market Share by Type (2012-2017)
4.3 United States Lipid-lowering Agent Price by Type (2012-2017)
4.4 United States Lipid-lowering Agent Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LIPID-LOWERING AGENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lipid-lowering Agent Sales and Market Share by Application (2012-2017)
5.2 United States Lipid-lowering Agent Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIPID-LOWERING AGENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lipid-lowering Agent Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Lipid-lowering Agent Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.2 Lipid-lowering Agent Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen
  6.4.2 Lipid-lowering Agent Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott
  6.5.2 Lipid-lowering Agent Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Lipid-lowering Agent Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.2 Lipid-lowering Agent Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 SUN Pharma
  6.8.2 Lipid-lowering Agent Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SUN Pharma Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Torrent Pharmaceuticals
  6.9.2 Lipid-lowering Agent Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Torrent Pharmaceuticals Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
  6.10.2 Lipid-lowering Agent Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GlaxoSmithKline Lipid-lowering Agent Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 HanAll BioPharma
6.12 JX Pharmaceuticals
6.13 Aurobindo Pharma
6.14 Abbvie
6.15 Cerenis Therapeutics

7 LIPID-LOWERING AGENT MANUFACTURING COST ANALYSIS

7.1 Lipid-lowering Agent Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lipid-lowering Agent

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lipid-lowering Agent Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lipid-lowering Agent Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIPID-LOWERING AGENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lipid-lowering Agent Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lipid-lowering Agent Sales Volume Forecast by Type (2017-2022)
11.3 United States Lipid-lowering Agent Sales Volume Forecast by Application (2017-2022)
11.4 United States Lipid-lowering Agent Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Lipid-lowering Agent
Figure United States Lipid-lowering Agent Market Size (K Units) by Type (2012-2022)
Figure United States Lipid-lowering Agent Sales Volume Market Share by Type (Product Category) in 2016
Figure Niaci Product Picture
Figure Acipimox Product Picture
Figure Fibrates Product Picture
Figure Others Product Picture
Figure United States Lipid-lowering Agent Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Lipid-lowering Agent by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Lipid-lowering Agent Market Size (Million USD) by Region (2012-2022)
Figure The West Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lipid-lowering Agent Sales (K Units) and Growth Rate (2012-2022)
Figure United States Lipid-lowering Agent Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lipid-lowering Agent Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Lipid-lowering Agent Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Lipid-lowering Agent Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lipid-lowering Agent Sales Share by Players/Suppliers
Figure 2017 United States Lipid-lowering Agent Sales Share by Players/Suppliers
Figure United States Lipid-lowering Agent Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lipid-lowering Agent Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lipid-lowering Agent Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lipid-lowering Agent Revenue Share by Players/Suppliers
Figure 2017 United States Lipid-lowering Agent Revenue Share by Players/Suppliers
Table United States Market Lipid-lowering Agent Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Lipid-lowering Agent Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Lipid-lowering Agent Market Share of Top 3 Players/Suppliers
Figure United States Lipid-lowering Agent Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lipid-lowering Agent Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lipid-lowering Agent Product Category
Table United States Lipid-lowering Agent Sales (K Units) by Region (2012-2017)
Table United States Lipid-lowering Agent Sales Share by Region (2012-2017)
Figure United States Lipid-lowering Agent Sales Share by Region (2012-2017)
Figure United States Lipid-lowering Agent Sales Market Share by Region in 2016
Table United States Lipid-lowering Agent Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lipid-lowering Agent Revenue Share by Region (2012-2017)
Figure United States Lipid-lowering Agent Revenue Market Share by Region (2012-2017)
Figure United States Lipid-lowering Agent Revenue Market Share by Region in 2016
Table United States Lipid-lowering Agent Price (USD/Unit) by Region (2012-2017)
Table United States Lipid-lowering Agent Sales (K Units) by Type (2012-2017)
Table United States Lipid-lowering Agent Sales Share by Type (2012-2017)
Figure United States Lipid-lowering Agent Sales Share by Type (2012-2017)
Figure United States Lipid-lowering Agent Sales Market Share by Type in 2016
Table United States Lipid-lowering Agent Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lipid-lowering Agent Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lipid-lowering Agent by Type (2012-2017)
Figure Revenue Market Share of Lipid-lowering Agent by Type in 2016
Table United States Lipid-lowering Agent Price (USD/Unit) by Types (2012-2017)
Figure United States Lipid-lowering Agent Sales Growth Rate by Type (2012-2017)
Table United States Lipid-lowering Agent Sales (K Units) by Application (2012-2017)
Table United States Lipid-lowering Agent Sales Market Share by Application (2012-2017)
Figure United States Lipid-lowering Agent Sales Market Share by Application (2012-2017)
Figure United States Lipid-lowering Agent Sales Market Share by Application in 2016
Table United States Lipid-lowering Agent Sales Growth Rate by Application (2012-2017)
Figure United States Lipid-lowering Agent Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Pfizer Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Pfizer Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Merck Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Merck Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Teva Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Teva Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Amgen Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Amgen Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Abbott Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Abbott Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure AstraZeneca Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure AstraZeneca Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Novartis Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Novartis Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table SUN Pharma Basic Information List
Table SUN Pharma Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure SUN Pharma Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure SUN Pharma Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure SUN Pharma Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table Torrent Pharmaceuticals Basic Information List
Table Torrent Pharmaceuticals Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Torrent Pharmaceuticals Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure Torrent Pharmaceuticals Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure Torrent Pharmaceuticals Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Lipid-lowering Agent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Lipid-lowering Agent Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Lipid-lowering Agent Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Lipid-lowering Agent Revenue Market Share in United States (2012-2017)
Table HanAll BioPharma Basic Information List
Table JX Pharmaceuticals Basic Information List
Table Aurobindo Pharma Basic Information List
Table Abbvie Basic Information List
Table Cerenis Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lipid-lowering Agent
Figure Manufacturing Process Analysis of Lipid-lowering Agent
Figure Lipid-lowering Agent Industrial Chain Analysis
Table Raw Materials Sources of Lipid-lowering Agent Major Players/Suppliers in 2016
Table Major Buyers of Lipid-lowering Agent
Table Distributors/Traders List
Figure United States Lipid-lowering Agent Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Lipid-lowering Agent Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lipid-lowering Agent Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Type in 2022
Table United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Application in 2022
Table United States Lipid-lowering Agent Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Lipid-lowering Agent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lipid-lowering Agent Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories